Abstract
Feline herpesvirus-1 (FHV-1) can cause lifelong problems such as rhinotracheitis and ocular disease due to latency and reactivation in affected cats. The particular effects of antiviral drugs have been separately investigated in previous studies for decades and little is known about the combination treatment in active FHV-1 infection. Therefore, we aimed to evaluate the effects of antiviral combination on clinical effectiveness in cats with naturally occurring FHV-1 infection. 28 cats suffering from clinical signs of sneezing, nasal congestion, conjunctivitis, and eye/nose discharge were involved in this study following FHV-1 DNA detection by PCR assay in oculo-oropharyngeal samples. The treatment protocol was as follows: oral famciclovir and L-lysine, ophthalmic acyclovir, and subcutaneous amoxicillin plus clavulanic acid. The symptoms improved each day and total recovery success rate was 80% reduction in clinical scores at the end of the treatment on day 10 (p<0.001). Additionally, PCR was found to be negative for FHV-1 DNA in 82.1% of the samples after the treatment. There were mild decreases in neutrophil and monocyte counts (p>0.05). The arginine to lysine ratio decreased in favour of lysine (p<0.01). As a result, the antiviral combination treatment with famciclovir, L-lysine and ophthalmic acyclovir, and antibacterial drug appears to be clinically effective for the treatment of naturally occurring active FHV-1 infection in cats. In addition, any adverse clinical effect has not been determined associated with the antiviral combination during the study.
Go to article
Bibliography
1. Bol S, Bunnik EM (2015) Lysine supplementation is not effective for the prevention or treatment of feline herpesvirus 1 infection in cats: a systematic review. BMC Vet Res 11: 284.
2. Cave NJ, Dennis K, Gopakumar G, Dunowska M (2014) Effects of physiologic concentrations of l-lysine on in vitro replication of feline herpesvirus 1. Am J Vet Res 75: 572-580.
3. Cooper AE, Thomasy SM, Drazenovich TL, Kass PH, Potnis SS, Leutenegger CM, Maggs DJ (2019) Prophylactic and therapeutic ef-fects of twice-daily famciclovir administration on infectious upper respiratory disease in shelter-housed cats. J Feline Med Surg 21: 544-552.
4. De Clercq E (2013) Antivirals: past, present and future. Biochem Pharmacol 85: 727-744.
5. Drazenovich TL, Fascetti AJ, Westermeyer HD, Sykes JE, Bannasch MJ, Kass PH, Hurley KF, Maggs DJ (2009) Effects of dietary ly-sine supplementation on upper respiratory and ocular disease and detection of infectious organisms in cats within an animal shelter. Am J Vet Res 70: 1391-1400.
6. Fascetti AJ, Maggs DJ, Kanchuk ML, Clarke HE, Rogers QR (2004) Excess dietary lysine does not cause lysine-arginine antagonism in adult cats. J Nutr 134: 2042s-2045s.
7. Fernandez M, Manzanilla EG, Lloret A, Leon M, Thibault JC (2017) Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydoph-ila felis and Mycoplasma felis DNA and associated risk factors in cats in Spain with upper respiratory tract disease, conjunctivitis and/or gingivostomatitis. J Feline Med Surg 19: 461-469.
8. Gaskell R, Dawson S, Radford A, Thiry E (2007) Feline herpesvirus. Vet Res 38: 337-354.
9. Gaskell RM, Povey RC (1977) Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec 100: 128-133.
10. Gould D (2011) Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options. J Feline Med Surg 13: 333-346.
11. Griffith RS, Norins AL, Kagan C (1978) A multicentered study of lysine therapy in Herpes simplex infection. Dermatologica 156: 257-267.
12. Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A (1987) Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica 175: 183-190.
13. Hussein IT, Menashy RV, Field HJ (2008) Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase. Antiviral Res 78: 268-274.
14. Inouye S, Hondo R (1993) Type differentiation of herpes simplex virus by stringent hybridization of polymerase chain reaction products. Arch Virol 129: 311-316.
15. Kopecny L, Maggs DJ, Leutenegger CM, Johnson LR (2020) Effects of famciclovir in cats with spontaneous acute upper respiratory tract disease. J Feline Med Surg 22: 492-499.
16. Lappin MR, Sebring RW, Porter M, Radecki SJ, Veir J (2006) Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1. J Feline Med Surg 8: 158-163.
17. Ledbetter EC, Badanes ZI, Chan RX, Donohue LK, Hayot NL, Harman RM, Van de Walle GR, Mohammed HO (2022) Comparative Efficacy of Topical Ophthalmic Ganciclovir and Oral Famciclovir in Cats with Experimental Ocular Feline Herpesvirus-1 Epithelial In-fection. J Ocul Pharmacol Ther 38: 339-347.
18. Low HC, Powell CC, Veir JK, Hawley JR, Lappin MR (2007) Prevalence of feline herpesvirus 1, Chlamydophila felis, and Mycoplasma spp DNA in conjunctival cells collected from cats with and without conjunctivitis. Am J Vet Res 68: 643-648.
19. Maggs DJ (2005) Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1. Clin Tech Small Anim Pract 20: 94-101.
20. Maggs DJ (2010) Antiviral therapy for feline herpesvirus infections. Vet Clin North Am Small Anim Pract 40: 1055-1062.
21. Maggs DJ, Clarke HE (2004) In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res 65: 399-403.
22. Maggs DJ, Collins BK, Thorne JG, Nasisse MP (2000) Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1. Am J Vet Res 61: 1474-1478.
23. Maggs DJ, Nasisse MP, Kass PH (2003) Efficacy of oral supplementation with L-lysine in cats latently infected with feline herpesvirus. Am J Vet Res 64: 37-42.
24. Mailoo VJ, Rampes S (2017) Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence. Integr Med (Encinitas) 16: 42-46.
25. Ozkanlar Y, Aktas MS, Kaynar O, Ozkanlar S, Kirecci E, Yildiz L (2012) Bovine respiratory disease in naturally infected calves: clinical signs, blood gases and cytokine response. Revue Med Vet 163: 123-130.
26. Ozkanlar Y, Aktas MS, Turkeli M, Erturk N, Oruc E, Ozkanlar S, Kirbas A, Erdemci B, Aksakal E (2014) Effects of ramipril and dar-bepoetin on electromechanical activity of the heart in doxorubicin-induced cardiotoxicity. Int J Cardiol 173: 519-521.
27. Ozkanlar Y, Nishijima Y, da Cunha D, Hamlin RL (2005) Acute effects of tacrolimus (FK506) on left ventricular mechanics. Pharmacol Res 52: 307-312.
28. Pedrazini MC, da Silva MH, Groppo FC (2022) L-lysine in herpesvirus reactivation after ChAdOx1 nCoV-19 vaccine (AZD1222): Minor literature review and case report. Dermatol Ther 35: e15291.
29. Rees TM, Lubinski JL (2008) Oral supplementation with L-lysine did not prevent upper respiratory infection in a shelter population of cats. J Feline Med Surg 10: 510-513.
30. Reinhard CL, McCobb E, Stefanovski D, Sharp CR (2020) A randomized, placebo-controlled clinical trial of famciclovir in shelter cats with naturally occurring upper respiratory tract disease. Animals (Basel) 10: 1448.
31. Stiles J (2003) Feline herpesvirus. Clin Tech Small Anim Pract 18: 178-185.
32. Stiles J, Townsend WM, Rogers QR, Krohne SG (2002) Effect of oral administration of L-lysine on conjunctivitis caused by feline her-pesvirus in cats. Am J Vet Res 63: 99-103.
33. Sykes JE, Allen JL, Studdert VP, Browning GF (2001) Detection of feline calicivirus, feline herpesvirus 1 and Chlamydia psittaci mu-cosal swabs by multiplex RT-PCR/PCR. Vet Microbiol 81: 95-108.
34. Sykes JE, Papich MG (2014) Antiviral and immunomodulatory drugs In: Sykes JE (ed) Canine and feline infectious diseases. Elsevier Saunders, Missouri, pp 54-65.
35. Thiry E, Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Truyen U, Horzinek MC (2009) Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 11: 547-555.
36. Thomasy SM, Lim CC, Reilly CM, Kass PH, Lappin MR, Maggs DJ (2011) Evaluation of orally administered famciclovir in cats ex-perimentally infected with feline herpesvirus type-1. Am J Vet Res 72: 85-95.
37. Thomasy SM, Maggs DJ (2016) A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1. Vet Ophthalmol 19 (Suppl 1): 119-130.
38. Thomasy SM, Shull O, Outerbridge CA, Lim CC, Freeman KS, Strom AR, Kass PH, Maggs DJ (2016) Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006-2013). J Am Vet Med Assoc 249: 526-538.
39. Vesanen M, Piiparinen H, Kallio A, Vaheri A (1996) Detection of herpes simplex virus DNA in cerebrospinal fluid samples using the polymerase chain reaction and microplate hybridization. J Virol Methods 59: 1-11.
40. Wieliczko AK, Płoneczka-Janeczko K (2010) Feline herpesvirus 1 and Chlamydophila felis prevalence in cats with chronic conjunctivitis. Pol J Vet Sci 13: 381-383.
41. Williams DL, Robinson JC, Lay E, Field H (2005) Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: results of a prospective clinical trial and data from in vitro investigations. Vet Rec 157: 254-257.
Go to article
en
pl
